MondegarAI
← Tracker

Institutional

GENERAL ATLANTIC, L.P.

CIK 0001017645
$2.15B
Reported AUM
12
Positions
Q1 2026
Period
2026-05-15
Filed

The Brief · GENERAL ATLANTIC, L.P. · Q1 2026

AI · grounded in 13F

GENERAL ATLANTIC, L.P. closed its entire position in Alignment Healthcare ALHC, reducing its exposure by $260,062,727. The fund also trimmed its holdings in Centessa Pharmaceuticals CNTA and Revolution Medicines RVMD, reducing share counts by 77.85% and 74.84% respectively. Conversely, the fund increased its stake in Alkami ALKT by 27.90%.

Portfolio · Q1 2026

DLO$605.1MCHYM$398.2MXP$391.6MALKT$240.3MPHVS$226.9MEWCZRVMDNRIXCNTAGL

Top holdings

QoQ vs Q4 2025

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1DLODLOCAL$11.24-4.50%8.95%-73.44%$605.1M28.17%HELD
2CHYMCHIME$17.48-3.74%-49.76%-49.20%$398.2M18.53%HELD
3XPXP, INC$15.34-1.92%-21.39%-58.09%$391.6M18.23%2,133,000−9.4%
4ALKTALKAMI$15.89-1.79%-47.83%-49.22%$240.3M11.19%+3,346,015+27.9%
5PHVSPHARVARIS$31.09-1.71%85.28%74.96%$226.9M10.56%HELD
6EWCZEUROPEAN WAX CENTER$5.82$75.8M3.53%HELD
7RVMDREVOLUTION MEDICINES$149.23-4.15%263.18%421.05%$68.8M3.20%2,105,137−74.8%
8NRIXNURIX THERAPEUTICS$14.64-4.19%14.55%-52.37%$63.6M2.96%795,294−16.2%
9CNTACENTESSA PHARMACEUTICALS$39.62-0.45%232.38%91.96%$53.8M2.50%4,762,885−77.9%
10RSKDRISKIFIED$4.75-1.25%-7.41%-85.27%$20.9M0.97%HELD
11GROVGROVE COLLABORATIVE$1.15-7.26%-12.88%-97.64%$3.2M0.15%HELD
12BULLWEBULL$5.60-8.20%-48.91%-43.72%$244K0.01%HELD
13ALHCALIGNMENT HEALTHCARE$15.371.99%0.99%-26.21%13,167,733EXITED

Source: SEC EDGAR · accession 0000950142-26-001406. 13F discloses long positions only — shorts, foreign equities, and options are excluded.